Test Price
2,800 AED✅ Home Collection Available
EFEMP2 Gene Cutis Laxa Type 1B (Autosomal Recessive) Genetic Test in UAE | 2800 AED | DHA Licensed
Executive Summary & Core Metrics
This comprehensive NGS-based genetic test analyzes the EFEMP2 gene to detect pathogenic variants causing autosomal recessive cutis laxa type 1B, with 99.9% diagnostic sensitivity under ISO 9001:2015 accredited processing.
- Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing
- Premium Logistics: VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM
- Clinical Guidance: Telephonic Post-Test Clinical Guidance in Result Interpretation
- Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731
Test Overview & Methodology
EFEMP2 gene testing identifies pathogenic variants responsible for autosomal recessive cutis laxa type 1B, a severe connective tissue disorder affecting skin, lungs, and vasculature, using comprehensive next-generation sequencing. This assay covers the full coding sequence and splice sites with high analytical sensitivity.
| Feature | Our Test (NGS) | Closest Alternative |
|---|---|---|
| Precision | Full gene sequencing with high analytical sensitivity | Targeted mutation analysis or fragmented Sanger sequencing |
| Methodology | Next Generation Sequencing (NGS) | Sanger Sequencing / limited NGS panel |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks |
Physician Insight & Safety Protocols
Advisory Precautions
Do not discontinue prescribed medication without consulting your doctor. Genetic test results should be interpreted in the context of full clinical evaluation and family history. Consult your specialist before making any treatment changes.
Exclusion Criteria & Emergency Red Flags
- Recent allogeneic bone marrow transplant (within 6 weeks) may interfere with DNA interpretation.
- Testing of minors without explicit legal guardian consent is prohibited. All genetic testing adheres to Federal Decree-Law No. 4 of 2016 on Medical Liability regarding patient consent.
- Seek emergency care if you experience sudden severe chest pain, acute dyspnea, or new skin ulceration – these may indicate vascular complications of cutis laxa.
Patient FAQ & Clinical Guidance
1. What exactly does the EFEMP2 gene test diagnose?
This NGS-based assay detects disease‑causing mutations in the EFEMP2 gene, confirming autosomal recessive cutis laxa type 1B with high specificity. It identifies variants responsible for severe connective tissue fragility.
2. How accurate is the genetic analysis for this condition?
Our NGS technology delivers over 99.9% analytical sensitivity for the full EFEMP2 coding sequence, reducing false negatives significantly. Confirmatory Sanger sequencing is performed for any identified variants.
3. Is home sample collection available in the UAE?
Yes, our VIP mobile phlebotomy service with temperature-controlled cold-chain logistics covers all Emirates with same-day scheduling from 8 AM to 11 PM. A standard peripheral whole blood draw is required.
4. How long do results take, and how will I receive them?
The turnaround time is 3–4 weeks from sample receipt. Results are delivered via a secure electronic report with a telephonic explanation from our clinical genetics team.
UAE Regulatory & Data Privacy Adherence
This diagnostic service complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. All genetic data is handled with strict confidentiality and security measures. Patient consent adheres to Federal Decree-Law No. 4 of 2016 on Medical Liability. Your results are stored in encrypted systems accessible only to authorized healthcare professionals.
Clinical & Logistical Metadata
| Test Name | EFEMP2 Gene Cutis Laxa Type 1B (Autosomal Recessive) Genetic Test |
| Price (AED) | 2,800 |
| Turnaround Time | 3–4 Weeks |
| Sample Type / Matrix | Peripheral whole blood (VIP Mobile Phlebotomy & Temperature-Controlled Cold-Chain Home Collection available daily from 8 AM to 11 PM) |
| Methodology Used | Next Generation Sequencing (NGS) – Full gene sequencing |
| ICD-10-CM Code | Q82.8 (Cutis laxa) |
| LOINC Code | 21665-7 (Gene mutations identified in Specimen by Sequencing) |
| DHA Facility License & Laboratory Address | Licence No: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians